Clinical Trial Update: Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether adding tiragolumab to atezolizumab plus carboplatin and etoposide improves outcomes in untreated extensive-stage small cell lun…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• CARBOPLATIN (Carboplatin)
• Etoposide (Etoposide)
• Tiragolumab (tiragolumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Small Cell Lung Carcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-10-29